Allianz Asset Management Gmb H Cytek Biosciences, Inc. Transaction History
Allianz Asset Management Gmb H
- $72.3 Billion
- Q4 2024
A detailed history of Allianz Asset Management Gmb H transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 50,700 shares of CTKB stock, worth $270,738. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,700
Previous 37,400
35.56%
Holding current value
$270,738
Previous $207,000
58.94%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CTKB
# of Institutions
140Shares Held
72.4MCall Options Held
400Put Options Held
0-
Black Rock Inc. New York, NY17.1MShares$91.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$62.9 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD9.49MShares$50.7 Million1.15% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$35.5 Million0.85% of portfolio
-
State Street Corp Boston, MA4.17MShares$22.3 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $719M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...